Clinical Trial Update: Clinical Performance and Safety of ENDOPACK® DT4-EBMCA in ACL Reconstruction 24 Months Post-surgery : Post-market Clinical Follow-up Study [NA]

View source ↗

Summary

A completed post-market follow-up trial evaluating the clinical performance and safety of ENDOPACK DT4-EBMCA used in anterior cruciate ligament reconstruction 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Cruciate Ligament Rupture

Drugs mentioned

• ENDOPACK DT4-EBMCA

Snippet

Sponsor: SACIMEX | Conditions: ACL Rupture | NA | Status: COMPLETED